Art shared a link to this Melatonin document the other day: Effect of melatonin administration on the PER1 and BMAL1 clock genes in patients with Parkinson’s disease sciencedirect.com/science/a...
This caught my eye: "Patients with PD exhibited an alteration in the levels of the clock genes: MEL increased the levels of BMAL1, but the PER1 levels remained unchanged."
"At the molecular level, expression of the BMAL1 and PER1 clock genes regulates this cycle through negative feedback. The BMAL1 forms a heterodimer with CLOCK, which allows for transcription of the PER1, PER2, CRY1, and CRY2 genes when binding to its E-box, and therefore the translation to their respective proteins: PER and CRY form a dimer, which, when phosphorylated, can enter the nucleus and inhibit the transcription of BMAL and CLOCK [4]. The PER1 has a wide oscillation, and BMAL1 is the central regulator of the biological clock in the SCN. In patients with PD, expression of the clock genes is altered [5,6]."
THIS IS WHERE I TAKE A LEFT TURN INTO SULFORAPHANE LAND:
NRF2 regulates core and stabilizing circadian clock loops, coupling redox and timekeeping in Mus musculus 2018 ncbi.nlm.nih.gov/labs/pmc/a... "We show here that chemical activation of NRF2 modifies circadian gene expression and rhythmicity, with phenotypes similar to genetic NRF2 activation. Loss of Nrf2 function in mouse fibroblasts, hepatocytes and liver also altered circadian rhythms, suggesting that NRF2 stoichiometry and/or timing of expression are important to timekeeping in some cells. Consistent with this concept, activation of NRF2 at a circadian time corresponding to the peak generation of endogenous oxidative signals resulted in NRF2-dependent reinforcement of circadian amplitude." (ANYBODY ELSE NOTICE THEY MENTIONED THE TIMING OF ACTIVATING THE NRF2?)
Clock Protein Bmal1 and Nrf2 Cooperatively Control Aging or Oxidative Response and Redox Homeostasis by Regulating Rhythmic Expression of Prdx6 2020 ncbi.nlm.nih.gov/labs/pmc/a... "we report for the first time that in lens/LECs, Nrf2, and its target genes, including Prdx6 expression and activities, are regulated by clock protein Bmal1, similar to other cell types and genes described previously [5]. We found Prdx6 to be a circadian protein that has rhythmic expression, which can be related to oxidative load and cellular requirements. Knockdown experimentation with Bmal1 results in increased ROS accumulation and reduced levels of antioxidant genes, along with their regulator Nrf2. Gain- and loss-of-function studies showed Bmal1 to be a major component for activation of Nrf2/Prdx6-mediated cellular protection."
Sulforaphane reactivates cellular antioxidant defense by inducing Nrf2/ARE/Prdx6 activity during aging and oxidative stress 2017 ncbi.nlm.nih.gov/labs/pmc/a... "A Nrf2 activator, Sulforaphane (SFN), augmented Prdx6, catalase and GSTπ expression in dose-dependent fashion, and halted Nrf2 dysregulation of these antioxidants. SFN reinforced Nrf2/DNA binding and increased promoter activities by enhancing expression and facilitating Nrf2 translocalization in nucleus. Conversely, promoter mutated at ARE site did not respond to SFN, validating the SFN-mediated restoration of Nrf2/ARE signaling. Furthermore, SFN rescued cells from UVB-induced toxicity in dose-dependent fashion, which was consistent with SFN’s dose-dependent activation of Nrf2/ARE interaction. Importantly, knockdown of Prdx6 revealed that Prdx6 expression was prerequisite for SFN-mediated cytoprotection. Collectively, our results suggest that loss of Prdx6 caused by dysregulation of ARE/Nrf2 can be attenuated through a SFN, to combat diseases associated with aging."
The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis 2014 genesdev.cshlp.org/content/... "Daily changes in the environment (cycles in light/darkness, feeding, rest–activity, and temperature fluctuations) inevitably expose the mammalian cells and tissues to periodic challenges, including oxidative insults from environmental toxins/pollutants and endogenously produced reactive metabolites as products of respiration (Patel et al. 2014)." AND "Current therapy that aims to slow down the progression of fibrotic diseases is often ineffective (Liu and Gaston Pravia 2009); our study implicates the need for considering circadian timing mechanisms, including timed drug administration (chronopharmacology) (Levi and Schibler 2007)."
I guess they have always said "timing is everything".